Brind.

Teva and Alvotech formed a strategic partnership on August 1, 2025.

2 reports, 1 independent Updated Aug 1
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Teva and Alvotech formed a strategic partnership on August 1, 2025.

Who's involved

What this event is mainly about
Alvotech

How it developed

Newest first. Tap a step to see who reported it.
  1. Teva and Alvotech announced a strategic partnership.1 source
  2. Alvotech and Teva developed Simlandi; Alvotech also partnered with Bayer on AVT06.1 source

Keep exploring

The entities involved

  • Alvotech

    biotechnology company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • ZacksTEVA Q2 Earnings Beat, Revenues Miss on Lower Generics Sales Teva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the Zacks Consensus E
  • ZacksAlvotech Gears Up to Report Q2 Earnings: Here's What to Expect Alvotech ALVO, a commercial-stage company developing and manufacturing biosimilar medicines for patients worldwide, is expected to annou